Edition:
India

Sihuan Pharmaceutical Holdings Group Ltd (0460.HK)

0460.HK on Hong Kong Stock

1.96HKD
11:54am IST
Change (% chg)

HK$-0.03 (-1.51%)
Prev Close
HK$1.99
Open
HK$1.97
Day's High
HK$1.97
Day's Low
HK$1.94
Volume
5,651,000
Avg. Vol
18,714,274
52-wk High
HK$3.76
52-wk Low
HK$1.92

Latest Key Developments (Source: Significant Developments)

Sihuan Pharmaceutical Holdings Posts ‍FY Profit Attributable Of RMB1.45 Bln
Tuesday, 27 Mar 2018 

March 27 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd <0460.HK>::FY REVENUE RMB2.75 BILLION VERSUS RMB3.19 BILLION.‍FY PROFIT ATTRIBUTABLE RMB1.45 BILLION VERSUS RMB1.71 BILLION.BOARD RECOMMENDS DECLARATION AND PAYMENT OF A FINAL CASH DIVIDEND OF RMB1.3 CENTS PER SHARE.‍ RECOMMENDS FINAL CASH DIVIDEND OF RMB1.3 CENTS PER SHARE​.  Full Article

Sihuan Pharmaceutical says unit to invest in Pharmadax Foshan
Monday, 4 Sep 2017 

Sept 4 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd <0460.HK>:Hainan Sihuan Pharmaceutical, a unit of co, recently entered into agreements with Pharmadax Inc.In first phase, group will subscribe for 19.99% equity interests in and corporate bonds issued by, Pharmadax Foshan at rmb200 million.  Full Article

Sihuan Pharmaceutical Holdings Group says HY revenue RMB 1.39 billion, down 21.8 pct<0460.HK>
Tuesday, 23 Aug 2016 

Sihuan Pharmaceutical Holdings Group Ltd <0460.HK>: Announcement of interim results for the six months ended 30 June 2016 <0460.HK> . HY profit attributable to owners of the company decreased by 49.3% to approximately RMB736.0 million . Interim dividend of RMB1.4 cents per share was declared by the board . It is expected that the government will maintain tight control over excessive growth in medical expenditure . Says HY revenue RMB 1.39 billion, down 21.8% . Lowering of provincial drug tender prices and implementation of "two-invoice system" to continue to pressure the pharmaceutical industry . Says rigid demand in the domestic pharmaceutical market will continue to grow .  Full Article